Abiopharma

Duos Edge AI to Host Corpus Christi Edge Data Center Open House

InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares

Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models

ESS Highlights Third-Party Utility Validating Iron Flow Battery Technology

BlockchAIn to Present at the 16th Annual LD Micro Invitational Conference on Tuesday, May 19, 2026

IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026

Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th

Publication date of reports for the first quarter of 2026 and a conference call on 20.5.26 in Hebrew at 10:00, in English at 15:00

Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease

UWM Holdings Corporation Announces First Quarter 2026 Results